Cite
Synthesis, radiosynthesis and In vivo evaluation of 5-[3-(4-Benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[11C]one, as a potent NR1A/2B subtype selective NMDA PET radiotracer
MLA
Roger, Gaëlle, et al. “Synthesis, Radiosynthesis and In Vivo Evaluation of 5-[3-(4-Benzylpiperidin-1-Yl)Prop-1-Ynyl]-1,3-Dihydrobenzoimidazol-2-[11C]One, as a Potent NR1A/2B Subtype Selective NMDA PET Radiotracer.” Bioorganic & Medicinal Chemistry, vol. 11, no. 24, Dec. 2003, p. 5401. EBSCOhost, https://doi.org/10.1016/j.bmc.2003.09.036.
APA
Roger, G., Lagnel, B., Besret, L., Bramoullé, Y., Coulon, C., Ottaviani, M., Kassiou, M., Bottlaender, M., Valette, H., & Dollé, F. (2003). Synthesis, radiosynthesis and In vivo evaluation of 5-[3-(4-Benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[11C]one, as a potent NR1A/2B subtype selective NMDA PET radiotracer. Bioorganic & Medicinal Chemistry, 11(24), 5401. https://doi.org/10.1016/j.bmc.2003.09.036
Chicago
Roger, Gaëlle, Béatrice Lagnel, Laurent Besret, Yann Bramoullé, Christine Coulon, Michelle Ottaviani, Michael Kassiou, Michel Bottlaender, Héric Valette, and Frédéric Dollé. 2003. “Synthesis, Radiosynthesis and In Vivo Evaluation of 5-[3-(4-Benzylpiperidin-1-Yl)Prop-1-Ynyl]-1,3-Dihydrobenzoimidazol-2-[11C]One, as a Potent NR1A/2B Subtype Selective NMDA PET Radiotracer.” Bioorganic & Medicinal Chemistry 11 (24): 5401. doi:10.1016/j.bmc.2003.09.036.